Aurobindo Pharma
-
August 16, 2022, Tuesday
USFDA approves Aurobindo Pharma owned Eugia's generic Vasopressin injection
Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US ...
-
August 11, 2022, Thursday
Aurobindo Pharma Q1 net profit down by 32% to Rs 520.5 cr; revenue up 9.4%
K Nithyananda Reddy, Vice-Chairman and Managing Director of the company said, investments in product portfolio continued at a ...
-
August 11, 2022, Thursday
Sensex up 515 pts, Nifty tops 17,650 on lower-than-expected US inflation
CLOSING BELL: Easing CPI figures reduced the probability of a 75-bps rate hike in the upcoming US FOMC meeting
-
August 03, 2022, Wednesday
Stocks to Watch: ONGC, Reliance, Zomato, Adani Wilmar, IndiGo,Vodafone Idea
Stocks to Watch today: Uber has decided to put its entire 7.8 per cent stake in Zomato on the block, according to sources.
-
August 02, 2022, Tuesday
Aurobindo Pharma's Andhra unit gets Form 483 with 3 USFDA observations
Aurobindo Pharma on Tuesday said the US health regulator has issued Form 483 with three observations after inspecting its ...
-
July 19, 2022, Tuesday
Rupee breaches 80: Watch out these levels on forex-sensitive Infy, IndiGo
Among select export-oriented shares, Aurobindo Pharma seems well placed on the charts with a potential upside of 9 per cent in ...
-
July 10, 2022, Sunday
Aurobindo Pharma to develop complex products, expand global footprint
Aurobindo Pharma remains focused on developing complex and differentiated products in multiple areas to drive the next phase of ...
-
June 28, 2022, Tuesday
Sensex, Nifty end flat after volatile session; metal, energy stocks shine
CLOSING BELL: M&M, Tech M, Dr Reddy's Labs, Reliance Industries, HCL Tech, and Tata Steel were the top gainers on the 30-pack ...
-
June 28, 2022, Tuesday
Stocks to watch: Bajaj Auto, TVS Motor, Tata Steel, Cipla, JSW Steel, FRL
Stocks to watch today: Bajaj Auto approved buyback of shares worth up to Rs 2,500 crore; Moody's upgraded Tata Steel's outlook to ...
-
June 27, 2022, Monday
Aurobindo Pharma receives Sebi's warning letter over ongoing USFDA audit
The letter is in regards to certain disclosures made by the company on the ongoing USFDA audit of company's Unit-1 and ...
